|
DTWD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.88737914186277E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.89626092605977E-12 |
| Normal-vs-Stage2 |
1.53341999999945E-05 |
| Normal-vs-Stage3 |
3.778000E-03 |
| Normal-vs-Stage4 |
5.621900E-02 |
| Stage1-vs-Stage2 |
8.910200E-01 |
| Stage1-vs-Stage3 |
1.706390E-01 |
| Stage1-vs-Stage4 |
5.564800E-01 |
| Stage2-vs-Stage3 |
3.531800E-01 |
| Stage2-vs-Stage4 |
6.638400E-01 |
| Stage3-vs-Stage4 |
8.126200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.76003656093826E-12 |
| Normal-vs-AfricanAmerican |
1.82329999987019E-08 |
| Normal-vs-Asian |
2.940000E-01 |
| Caucasian-vs-AfricanAmerican |
6.439800E-01 |
| Caucasian-vs-Asian |
4.504600E-01 |
| AfricanAmerican-vs-Asian |
5.783000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.7715611723761E-15 |
| Normal-vs-Female |
2.11310000000076E-05 |
| Male-vs-Female |
1.178470E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.39279999995013E-07 |
| Normal-vs-Extreme_Weight |
2.4535928844216E-14 |
| Normal-vs-Obese |
8.98079999256396E-09 |
| Normal-vs-Extreme_Obese |
2.774300E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.270800E-01 |
| Normal_Weight-vs-Obese |
5.581600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.993200E-01 |
| Extreme_Weight-vs-Obese |
1.060240E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.566400E-01 |
| Obese-vs-Extreme_Obese |
7.870400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.027100E-04 |
| Normal-vs-Age(41-60Yrs) |
1.33190003470673E-09 |
| Normal-vs-Age(61-80Yrs) |
2.85327317328665E-14 |
| Normal-vs-Age(81-100Yrs) |
5.05559999974814E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.349400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.540200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.186200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.842400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.091400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.489600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.63080660087189E-12 |
| Normal-VS-Type2 PRCC |
2.04520000000041E-05 |
| Normal-VS-KIRP CIMP |
2.4275026433429E-11 |
| Normal-VS-Unclassified PRCC |
9.554200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.373790E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.257800E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.202400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.415830E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
9.983800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.150300E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.911399981682E-09 |
| Normal-vs-N1 |
4.777600E-03 |
| Normal-vs-N2 |
7.06820000306863E-08 |
| N0-vs-N1 |
2.237600E-01 |
| N0-vs-N2 |
1.546800E-01 |
| N1-vs-N2 |
1.461610E-03 |
|
|
